Tokyo, Jan. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060477) titled 'Exploratory Secondary Analysis of the Efficacy of Test Foods in Improving Menstrual Symptoms' on Jan. 27.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Ezaki Glico Co., Ltd.
Condition:
Condition - Healthy Adult
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - An exploratory secondary analysis using data from a previously conducted trial (UMIN000055337) aims to identify factors influencing the efficacy of the test food in improving menstrual-related symptoms in women aged 25 to 40 with normal menstrual cycles who experience such symptoms.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 25
years-old
=
Gender - Female
Key inclusion criteria - Since participants were selected from those who had already enrolled in the existing randomized double-blind parallel-group trial (UMIN000055337), no new key inclusion criteria were established.
Key exclusion criteria - Since participants were selected from those who had already enrolled in the existing randomized double-blind parallel-group trial (UMIN000055337), no new key exclusion criteria were established.
Target Size - 464
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 01 Month 22 Day
Date of IRB - 2026 Year 01 Month 22 Day
Anticipated trial start date - 2026 Year 01 Month 27 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069180
Disclaimer: Curated by HT Syndication.
